Daito Pharmaceutical Co.,Ltd. (4577.T)
JPY 2025.0
(0.75%)
JPY 2025.0
(0.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 46.89 Billion | 45.1 Billion | 43.46 Billion | 48.7 Billion | 44.99 Billion | 41.13 Billion |
| Cost of Revenue | 37.05 Billion | 34.77 Billion | 32 Billion | 37.91 Billion | 35.51 Billion | 32.46 Billion |
| Gross Profit | 9.83 Billion | 10.33 Billion | 11.45 Billion | 10.79 Billion | 9.48 Billion | 8.67 Billion |
| Operating Expenses | 5.94 Billion | 5.12 Billion | 4.9 Billion | 4.88 Billion | 4.12 Billion | 4.12 Billion |
| Selling, General and Administrative Expenses | 3.43 Billion | 3.07 Billion | 2.99 Billion | 2.71 Billion | 2.6 Billion | 2.39 Billion |
| Research and Development Expenses | 2.34 Billion | 1.86 Billion | 1.74 Billion | 2.03 Billion | 1.4 Billion | 1.6 Billion |
| Other Expenses | 165 Million | 3 Million | 37 Million | 28.4 Million | 28.76 Million | 28.29 Million |
| Cost and Expenses | 43 Billion | 39.89 Billion | 36.91 Billion | 42.8 Billion | 39.63 Billion | 36.58 Billion |
| Operating Income | 3.89 Billion | 5.2 Billion | 6.55 Billion | 5.9 Billion | 5.35 Billion | 4.54 Billion |
| Interest Expense | 41 Million | 12 Million | 9 Million | 7.85 Million | 11.88 Million | 20.89 Million |
| Income Tax Expense | 1.04 Billion | 1.54 Billion | 2.09 Billion | 1.71 Billion | 1.67 Billion | 1.12 Billion |
| Earnings before Tax | 4.21 Billion | 5.07 Billion | 6.72 Billion | 5.87 Billion | 5.59 Billion | 4.61 Billion |
| Net Income | 3.29 Billion | 3.6 Billion | 4.66 Billion | 4.24 Billion | 3.94 Billion | 3.51 Billion |
| Earnings Per Share Basic | 209.99 | 227.64 | 304.90 | 282.75 | 281.51 | 255.23 |
| Earnings Per Share Diluted | 209.99 | 227.45 | 304.90 | 282.75 | 279.51 | 255.23 |
| Weighted Average Shares Outstanding | 15.69 Million | 15.81 Million | 15.3 Million | 15.01 Million | 14.01 Million | 13.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.69 Million | 15.82 Million | 15.3 Million | 15.01 Million | 14.11 Million | 13.76 Million |
| Gross Margin | 0.21 | 0.23 | 0.26 | 0.22 | 0.21 | 0.21 |
| EBIT Margin | 0.16 | 0.20 | 0.23 | 0.19 | 0.19 | 0.18 |
| Profit Margin | 0.07 | 0.08 | 0.11 | 0.09 | 0.09 | 0.09 |
| EBITDA | 7.55 Billion | 9.08 Billion | 9.88 Billion | 9.03 Billion | 8.55 Billion | 7.49 Billion |
| Earnings Before Tax Margin | 0.08 | 0.12 | 0.15 | 0.12 | 0.12 | 0.11 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 12.67 Billion | 46.89 Billion | 12.23 Billion | 10.55 Billion | 11.93 Billion | 12.17 Billion |
| Cost of Revenue | 10.42 Billion | 37.05 Billion | 9.68 Billion | 8.44 Billion | 9.21 Billion | 9.7 Billion |
| Gross Profit | 2.25 Billion | 9.83 Billion | 2.54 Billion | 2.1 Billion | 2.71 Billion | 2.47 Billion |
| Operating Expenses | 1.4 Billion | 5.94 Billion | 1.75 Billion | 1.29 Billion | 1.5 Billion | 1.39 Billion |
| Selling, General and Administrative Expenses | 1.4 Billion | - | 1.75 Billion | 808 Million | 880 Million | 776 Million |
| Research and Development Expenses | - | - | 623 Million | 482 Million | 627 Million | 617 Million |
| Other Expenses | - | 2 Million | 3 Million | -12 Million | 6 Million | 5 Million |
| Cost and Expenses | 11.82 Billion | 43 Billion | 11.44 Billion | 9.73 Billion | 10.72 Billion | 11.09 Billion |
| Operating Income | 850 Million | 3.89 Billion | 789 Million | 815 Million | 1.2 Billion | 1.08 Billion |
| Interest Expense | 17 Million | 41 Million | 19 Million | 13 Million | 6 Million | 3 Million |
| Income Tax Expense | 914 Million | 1.04 Billion | -130 Million | 349 Million | 392 Million | 429 Million |
| Earnings before Tax | 1.39 Billion | 4.21 Billion | 778 Million | 1.12 Billion | 1.22 Billion | 1.09 Billion |
| Net Income | 617 Million | 3.29 Billion | 956 Million | 787 Million | 869 Million | 683 Million |
| Earnings Per Share Basic | 40.41 | - | 60.91 | 50.13 | 54.99 | 43.22 |
| Earnings Per Share Diluted | 40.41 | - | 60.91 | 50.13 | 54.99 | 43.22 |
| Weighted Average Shares Outstanding | 15.29 Million | 15.69 Million | 15.69 Million | 15.69 Million | 15.8 Million | 15.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.29 Million | 15.69 Million | 15.69 Million | 15.69 Million | 15.8 Million | 15.8 Million |
| Gross Margin | 0.18 | 0.21 | 0.21 | 0.20 | 0.23 | 0.20 |
| EBIT Margin | 0.19 | - | 0.15 | 0.16 | 0.10 | 0.09 |
| Profit Margin | 0.05 | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 |
| EBITDA | 2.45 Billion | - | 1.84 Billion | 1.71 Billion | 1.21 Billion | 1.09 Billion |
| Earnings Before Tax Margin | 0.07 | 0.08 | 0.06 | 0.08 | 0.10 | 0.09 |
6237
SPH
NAVINFLUOR
DBOEY
ZDPY
5257